ESC 365 - Atrial fibrillation

ESC Premium Access

Atrial fibrillation

Event: ESC CONGRESS 2017

Topic: Drug therapy

Session type: Guidelines in Practice

Date: 29 August 2017

Time: 08:30 - 10:00

Congress Session

8 presentations in this session

Gastrointestinal bleeding in an atrial fibrillation patient

Speaker: Doctor T. Hall (Oslo, NO)

Gastrointestinal bleeding in an atrial fibrillation patient - What do the Guidelines say?

Speaker: Professor B. Popescu (Bucharest, RO)

Gastrointestinal bleeding in an atrial fibrillation patient. How to implement the Guidelines – Panel discussion

Gastrointestinal bleeding in an atrial fibrillation patient - Conclusion and take home message.

Speaker: Professor C. Torp-Pedersen (Hilleroed, DK)

New onset atrial fibrillation: which drug to choose for cardioversion.

Speaker: Doctor J. Poess (Leipzig, DE)

New onset atrial fibrillation: which drug to choose for cardioversion - What do the Guidelines say?

Speaker: Professor J. Steffel (Zurich, CH)

New onset atrial fibrillationn: which drug to choose for cardioversion. How to implement the Guidelines – Panel discussion

New onset atrial fibrillation: which drug to choose for cardioversion - Conclusion and take home message.

Speaker: Professor J. Tamargo (Madrid, ES)

6 speakers from this session

Doctor Trygve Sundby Hall

Oslo University Hospital Ulleval, Oslo (Norway)

4 presentations

0 follower

Professor Bogdan Alexandru Popescu

Emergency Institute for Cardiovascular Diseases Prof. Dr. C.C. Iliescu, Bucharest (Romania)

32 presentations

0 follower

Professor Christian Torp-Pedersen

Nordsjaellands Hospital, Hilleroed (Denmark)

5 presentations

0 follower

Doctor Janine Poess

Heart Center of Leipzig, Leipzig (Germany)

11 presentations

0 follower

Professor Jan Steffel

Swiss EP AG, Zurich (Switzerland)

57 presentations

8 followers

Professor Juan Tamargo

Complutense University of Madrid, Madrid (Spain)

8 presentations

2 followers

This platform is supported by